This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC ...

Abstract Highlights ORIC-944 is a potent, highly selective, orally bioavailable, allosteric inhibitor of PRC2 that demonstrates best-in-class drug properties, including potency, solubility, and ...

The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

Greenhouse gas emissions related to pharmaceutical consumption increased by 77% over the past 24 years, according to a Leiden ...

Enzymes – proteins that speed chemical reactions – are commonly used in the pharmaceutical industry. But figuring out which ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

Ascentage Pharma Group International ( ($HK:6855) ) has issued an update. Ascentage Pharma announced the selection of five preclinical studies ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and the performance of ...